共 41 条
[12]
Clinical characterization and molecular mechanisms of statin myopathy .2 Toth Peter P,Harper Charles R,Jacobson Terry A. Expert review of cardiovascular therapy . 2008
[13]
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials .2 B. Mihaylova,J. Emberson,L. Blackwell. LANCET . 2012
[14]
Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin[J] . David D. Waters,Jennifer E. Ho,David A. DeMicco,Andrei Breazna,Benoit J. Arsenault,Chuan-Chuan Wun,John J. Kastelein,Helen Colhoun,Philip Barter.Journal of the American College of Cardiology . 2011 (14)
[15]
Myopathy: Five New Things[J] . Neurology . 2011 (7_Su)
[16]
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J] . Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R Pedersen,
[19]
Statin Induced Myopathy[J] . Sivakumar Sathasivam,Bryan Lecky.BMJ: British Medical Journal . 2008 (7679)
[20]
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial[J] . GISSI-HF investigators.The Lancet . 2008 (9645)